Trials / Completed
CompletedNCT05063266
Effects of Inspiratory Muscle Training in Pulmonary Hypertensive Patient
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- Riphah International University · Academic / Other
- Sex
- All
- Age
- 40 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Although the progressive nature of pulmonary hypertension (PH), including the impairment of respiratory muscle function, studies have demonstrated beneficial effects of physical exercise on the functional limitations caused by the disease in this population, being an important collaborator to the conventional drug therapy.Respiratory muscle training (RMT) improves functional capacity and quality of life (QoL) in patients.A randomized controlled trial was conducted to evaluate the effectiveness of this protocol on respiratory muscle strength and endurance, functional capacity. 18 subjects were allocated in 2 groups, group A was control group and group B was experimental group. Group A or Control group received deep breathing exercises. Group B received 30 minutes of IMT 6days weekly for 2 weeks by using a pressure threshold device. The purpose of this study was to investigate the effects of inspiratory muscle training (IMT) in PAH. To evaluate effectiveness of IMT mouth pressure device ,functional capacity using 6 minute walking test (6MWT)health assessment via SF 36 questionnaire were used before and after training protocol.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Deep Breathing Exercise | control groups received deep breathing exercise 6 days a week for two weeks. Deep breathing exercises includes diaphragmatic breathing and pursed lip breathing. |
| OTHER | Inspiratory muscle Training | Treatment group received inspiratory muscle training 20 minutes 6 days a week for two weeks.IMT was done by using pressure threshold device. |
Timeline
- Start date
- 2020-10-13
- Primary completion
- 2021-07-02
- Completion
- 2021-07-15
- First posted
- 2021-10-01
- Last updated
- 2021-10-01
Locations
1 site across 1 country: Pakistan
Source: ClinicalTrials.gov record NCT05063266. Inclusion in this directory is not an endorsement.